ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Forms Task Force To Examine Marin County Breast Cancer Incidence

November 15, 2002

Kennedy Attempts To Establish Unit For All Biomedical Research Similar To Successful Cancer Panel; Administration Threatens Veto

March 15, 1974

House Launches Probe of NCI Spending On Cancer Communications, Education

April 12, 2013

PI Defends NCI’s National Lung Screening Trial As “Rigorous” Randomized Trial.

November 3, 2006

The Tivozanib Timeline

May 10, 2013

NCI to Fund Research Collaboration At HMOs, Health Care Provider Networks

July 11, 1997